Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
Status:
Recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
To determine whether a reduced volume hydration regimen will lead to a shorter time to
methotrexate clearance when compared to a standard intravenous (IV) hydration regimen.